[
  {
    "ts": "2026-02-02T14:17:00+00:00",
    "headline": "Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances",
    "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and insulin‑requiring type 2 diabetes. These milestones include Medicare access for the MiniMed™ 780G system paired with the Instinct sensor, made by Abbott, FDA clearance for the system's use with ultra rapid‑acting insulins, and clearance of the MiniMed™ 780G system for use with the Instinct sensor for insul",
    "url": "https://finance.yahoo.com/news/medtronic-diabetes-expands-access-full-141700080.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "468bc25d-4112-366a-907b-b0b6ee59d85f",
      "content": {
        "id": "468bc25d-4112-366a-907b-b0b6ee59d85f",
        "contentType": "STORY",
        "title": "Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances",
        "description": "",
        "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and insulin‑requiring type 2 diabetes. These milestones include Medicare access for the MiniMed™ 780G system paired with the Instinct sensor, made by Abbott, FDA clearance for the system's use with ultra rapid‑acting insulins, and clearance of the MiniMed™ 780G system for use with the Instinct sensor for insul",
        "pubDate": "2026-02-02T14:17:00Z",
        "displayTime": "2026-02-02T14:17:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/510c2e1f8106182542990a1d044f35de",
          "originalWidth": 300,
          "originalHeight": 400,
          "caption": "Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dV0rd8nUQNqgVCKbGDoBTA--~B/aD00MDA7dz0zMDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/510c2e1f8106182542990a1d044f35de.cf.webp",
              "width": 300,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lyN2grpZIoZUTPpO9CSUKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/510c2e1f8106182542990a1d044f35de.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-diabetes-expands-access-full-141700080.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-diabetes-expands-access-full-141700080.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-02T14:08:00+00:00",
    "headline": "4 Medical Product Stocks to Watch From a Challenging Industry",
    "summary": "The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.",
    "url": "https://finance.yahoo.com/news/4-medical-product-stocks-watch-140800504.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c0e01b5a-03bf-3a8f-9ac8-fe250ce0f9ea",
      "content": {
        "id": "c0e01b5a-03bf-3a8f-9ac8-fe250ce0f9ea",
        "contentType": "STORY",
        "title": "4 Medical Product Stocks to Watch From a Challenging Industry",
        "description": "",
        "summary": "The Zacks Medical products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. BSX, RMD, PAHC and BLFS reflect the favorable fundamentals.",
        "pubDate": "2026-02-02T14:08:00Z",
        "displayTime": "2026-02-02T14:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/54CAf0a.xcVnm138kMlg2g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qq8AX6cTgCCg_4Ye3FJ4Gw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/4-medical-product-stocks-watch-140800504.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/4-medical-product-stocks-watch-140800504.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAX"
            },
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-02T17:05:00+00:00",
    "headline": "The Best Dividend King to Buy With $150",
    "summary": "The stock is near its 52-week low.",
    "url": "https://www.fool.com/investing/2026/02/02/the-best-dividend-king-to-buy-with-150/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "76e4bed2-b7a5-3c9d-8a15-08dba3d26d0d",
      "content": {
        "id": "76e4bed2-b7a5-3c9d-8a15-08dba3d26d0d",
        "contentType": "STORY",
        "title": "The Best Dividend King to Buy With $150",
        "description": "",
        "summary": "The stock is near its 52-week low.",
        "pubDate": "2026-02-02T17:05:00Z",
        "displayTime": "2026-02-02T17:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/4dd565ebccfe8d0254b6d01e2d43ad87",
          "originalWidth": 1400,
          "originalHeight": 738,
          "caption": "Doctor talking to patient.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OhW__bKcp.HkuV3gdGHZhA--~B/aD03Mzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/4dd565ebccfe8d0254b6d01e2d43ad87.cf.webp",
              "width": 1400,
              "height": 738,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T1H8L2PdqXqwyyno2JyPgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/4dd565ebccfe8d0254b6d01e2d43ad87.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/02/the-best-dividend-king-to-buy-with-150/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-dividend-king-buy-150-170500452.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-02T16:40:02+00:00",
    "headline": "NVST or ABT: Which Is the Better Value Stock Right Now?",
    "summary": "NVST vs. ABT: Which Stock Is the Better Value Option?",
    "url": "https://finance.yahoo.com/news/nvst-abt-better-value-stock-164002749.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d9447d6a-0f0a-31ef-9661-f6764e6f8908",
      "content": {
        "id": "d9447d6a-0f0a-31ef-9661-f6764e6f8908",
        "contentType": "STORY",
        "title": "NVST or ABT: Which Is the Better Value Stock Right Now?",
        "description": "",
        "summary": "NVST vs. ABT: Which Stock Is the Better Value Option?",
        "pubDate": "2026-02-02T16:40:02Z",
        "displayTime": "2026-02-02T16:40:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SVlgtyKcqJmTvHzvwqjZfA--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7KqPU5XU5bEHAxdnZQ3L5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvst-abt-better-value-stock-164002749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvst-abt-better-value-stock-164002749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVST"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-02T20:12:46+00:00",
    "headline": "Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset",
    "summary": "Abbott Laboratories (NYSE:ABT) agreed to acquire Exact Sciences for US$21b. The deal is set to reshape Abbott's diagnostics business by adding a broad cancer testing platform. Management is also rolling out changes in the Nutrition segment in response to ongoing operational challenges. For you as an investor, the Exact Sciences deal puts a spotlight on Abbott's push deeper into cancer diagnostics, an area that continues to attract significant attention across healthcare. At the same time,...",
    "url": "https://finance.yahoo.com/news/abbott-exact-sciences-deal-recasts-201246493.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "dffd09f8-ce8f-391c-994c-522d57791cc5",
      "content": {
        "id": "dffd09f8-ce8f-391c-994c-522d57791cc5",
        "contentType": "STORY",
        "title": "Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset",
        "description": "",
        "summary": "Abbott Laboratories (NYSE:ABT) agreed to acquire Exact Sciences for US$21b. The deal is set to reshape Abbott's diagnostics business by adding a broad cancer testing platform. Management is also rolling out changes in the Nutrition segment in response to ongoing operational challenges. For you as an investor, the Exact Sciences deal puts a spotlight on Abbott's push deeper into cancer diagnostics, an area that continues to attract significant attention across healthcare. At the same time,...",
        "pubDate": "2026-02-02T20:12:46Z",
        "displayTime": "2026-02-02T20:12:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-exact-sciences-deal-recasts-201246493.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-exact-sciences-deal-recasts-201246493.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "EXAS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]